The Fellowship Council

Display Listing

You are here: Home / Directory of Fellowships / Display Listing

Program Director(s):
D. Rohan Jeyarajah
Danielle Giesler

Return to Browse

Description:

The Complex Gastrointestinal (CGI) Surgery Fellowship at Methodist Richardson Medical Center (MRMC) has been developed to provide exposure and in depth experience to open, endoscopic, laparoscopic, and robotic approaches to complex foregut, midgut, and hindgut procedures as a supplement to the general surgery residency training. The diverse and supportive faculty will allow the fellow to experience a wide variety of surgical disease processes including foregut, midgut, hepatopancreaticobiliary (HPB), colorectal, and complex abdominal wall reconstruction cases. There is an especially large volume of foregut and HPB cases performed at MRMC, allowing for a symbiotic training track along with the HPB fellow. In addition, we have a strong GI faculty without a competing GI fellowship which will allow for a robust endoscopy rotation with exposure to ERCP and EUS. The fellows share in-patient duties with the HPB fellow and follow their patients to ensure continuity of care by participating in weekly outpatient clinics, operations, and inpatient admissions. The fellow will be intimately involved in weekly didactic meetings, morbidity and mortality conferences, GI conferences, tumor boards, and other relevant educational gatherings.

In addition to the robust clinical experience, the fellow is expected to perform clinical and outcomes research. The fellow will have ample resources and support to prepare abstracts and manuscripts for peer reviewed journals for publication as well as the opportunity to present at regional and national meetings such as SSAT, AHPBA, and SAGES. We expect at least two manuscripts to be submitted and published during the fellow's time.

The aim of this fellowship is to bridge the gap between general surgery residency and the next step in the candidate’s career, whether it is to prepare the trainee for a busy practice in complex GI surgery. The faculty feel that this could be in an academic setting or in a large community setting - but we expect that the fellow will remain actively involved in academic endeavors with a commitment to discovery and inquisitive practice. The graduate felow should be the "go to" person in this work enviorment.

Basic Program Information:

  • Location: Richardson, Texas
  • Primary Program Site: Methodist Richardson Cancer Center
  • Primary Hospital: Total bed size, # OR's, # Surgical ICU beds: 348 Total Beds, 9 ORs, 25 Surgical ICU Beds
  • Secondary Program Site:
  • Secondary Hospital: Total bed size, # OR's, # Surgical ICU beds:
  • Clinic locations and schedule:

    Methodist Richardson Cancer Center

    Faculty members  have total of 5 days of clinic a week - Fellow is required to attend one day a week. 

  • University Affiliation: None
  • School of Medicine Affiliation: TCU Burnett School of medicine
  • Year Program and/or Designation Established: 2017
  • Number of Faculty: 5
  • % of Program Clinical: 85
  • % of Program Research: 15

Additional Program Information:

  • Interaction with Residents: Share cases with residents
  • Is there a General Surgery Residency at the Primary Institution? Yes
  • Is there a General Surgery Residency at the Secondary Institution? No
  • Is there a curriculum in place for fellowship? Yes
  • Is there a skills lab at the institution with fellow access? Yes
  • Are there teaching conferences available for the fellow? Yes
  • Is there an evaluation tool for fellow by faculty in place? Yes
  • Is there an evaluation tool for faculty by fellow in place? Yes
  • Papers Accepted For Publication where PD was an author: 49
  • Publications that Involved Input from the Fellow: 3
  • Are funds available for the Fellow to attend conferences? Yes

Malpractice Insurance Information:

  • The fellow(s) only works as a fellow, i.e. does not/will not have attending privileges and the program provides the following:
    Claims-based malpractice coverage including a tail for the statute of limitations

Contact Information For Questions:

Anitha Varghese
Phone: 469-204-6182
Fax: 214-947-2361
Email: AnithaVarghese@mhd.com
Web: https://www.methodisthealthsystem.org/medical-education/graduate-medical-education/fellowships/complex-gi-fellowship/

Facilities

Dry Lab
Library
Administrative Support
Clinical Research
Simulation Lab

Citizenship and Visa Requirements:

    US Citizens
    US Permanent Residents (Green Card)
    Non U.S./Non Canadian Citizens
    Non U.S. Citizens eligible for/with planned J-1 Visa during their fellowship (For U.S. Fellowship Programs)

Medical School Requirements:

    We accept graduates of U.S. or Canadian Medical Schools and Foreign Medical Schools
    We accept graduates of Foreign Medical Schools only if ECFMG Certified

Examinations and Certifications:

    Applicants must have passed the USMLE/COMLEX Step 1, 2, & 3 exams
    Applicants must have had at least 2 years of prior training in an ACGME accredited residency or fellowship (or Canadian equivalent)
    Applicants who are ABS or Canadian Board Eligible or Certified
    Applicants must have had at least 2 years of prior training in an AOA (American Osteopathic Association) accredited residency or fellowship
    Applicants must be AOBS (American Osteopathic Board of Surgery) eligible or certified

 

Licensure Requirements and Information:

Full state licensure is not required, however, applicant must be eligible for a Permit In Training (PIT) through the state of Texas. Please see requriements for this on TSBME website. This will be obtained as part of the onboarding process after the candidate is accepted into the fellowship.

Accreditation Status Accreditation Period Length of Accreditation
Accredited for Complex Gastrointestinal Surgery/Foregut 2023-2026 3

Fellowship Opportunity # 1

  • Number of Positions Available: 1
  • Type of Fellowship: Complex Gastrointestinal Surgery
  • Duration: 1 year
  • Start Day: August 1
  • End Day: July 31
  • Is this a salaried position? Yes
  • It is a requirement that the salary must be commensurate to a PGY 6 or greater in the same city. Does your program meet this requirement? Yes
  • Is the salary guaranteed for the year? Yes
  • Is there funding available beyond salary for meeting attendance, research, etc? Yes
  • Is the salary dependent on call? No
  • Is the Fellow on call? Yes
    What are the on call requirements?

    Management of the in house AGI Patients. 
  • What are the estimated fellow weekly work hours? 60
  • It is a requirement that Health Insurance be provided. Do you provide health insurance to your fellows? Yes
  • Teaching Responsibilities: Yes
  • Courses/Academic Presentations: Yes
  • Does reimbursement for the above make up part of the salary? No
  • Does the fellowship contract include a non-compete clause? No

Clinical Outpatient Experience

The fellow participates in outpatient clinic with faculty 1 day per week. The fellow is expected to be actively involved in perioperative workup and management of complex Complex GI both benign and malignant.

Research/Scholarship Resources

The fellow will be expected to perform at least three research projects during their time with us, There are students that help collect data, but the fellow will be primarily responsible for the research. We will target ACS, SSAT, AHPBA and SAGES. A research fellow and a statistician are avalible onsite. The fellow work closely with the research fellow. These will be resources through TCU School of Medicine for library services.  

Program Director(s) Detailed Information

Dr. D. Rohan Jeyarajah MD FACS

  • At Institution Since: 2007
  • Program Director Since : 2017
  • Board Certification: Board Certified

Society Memberships

SAGES

ACS

SSAT

AHPBA

Other

SSO

Areas of Expertise

HPB Foregut and Complex GI Surgery

Teaching Qualifications

Summary of Qualifications

Summary of Qualifications

Residency and Fellowships Obtained:

RESIDENCY University of Chicago, Chicago, IL, General Surgery 1989 – 1996

FELLOWSHIPS University of Chicago, NIH Fellowship in Transplant Immunology 1991 – 1993 Baylor University Medical Center, Transplant Surgery Fellow 1996 – 1997

Leadership and Teaching roles (national and local)

TCU and UNTHSC School of Medicine

Chair, Department of Surgery

February 2018 - present

Associate Program Director,

General Surgery Residency,

Methodist Health System

July 2019 – present

 

Methodist Richardson Medical Center

Director, GI Surgical Services

July 2016-present

 

Methodist Dallas Medical Center

Director, Surgical Oncology

Sept 2005-January 2018

 

Methodist Health System

Program Director, HPB Surgical Fellowship

July 2006-present

 

Methodist Health System

Program Director, Advanced GI Surgical Fellowship

July 2017 - present

 

Methodist Dallas Medical Center

Vice Chair, Clinical Research Institute-Research Advisory Board

2013-present

 

University of North Texas Health Science Center

Adjunct Clinical Professor of Surgery

2012- present

 

Uniformed Services University of the Health Sciences

Adjunct Assistant Professor of Surgery

2015 - present

 

University of Texas Southwestern Medical Center, Dallas, Texas

Associate Professor, Department of Surgery

2003 – 2005

University of Texas Southwestern Medical Center, Dallas, Texas

Assistant Professor, Department of Surgery

1997 – 2003 

University of Texas Southwestern Medical Center, Dallas, Texas

Director, Surgical Continuing Medical Education

June 2004 –August 2005

Individual Societies

American College of Surgeons

       Chair, Nominating Committeee of Fellows – (2022-2023)

       Member, Nominating Committee of Fellows – (2019-2022)      

       Member of the Executive Committee, Communications Pillar Lead, ACS (2019-2020)

       Governor, ACS - (2014-2020)

       Co-chair, newsletter workgroup ACS – (2017-2018)

       Chair, Newsletter Workgroup ACS – (2018-2019)

       Editorial Advisor to the ACS Bulletin- (2018-2023)

       President, North Texas American College of Surgeons – (2015-2016)

       Member, ACS workgroup on Complex GI Surgery – (2018-present)

       Co-chair, Program Committee, North Texas Chapter of ACS – (2011-2014)

       Member ACS Committee on Applicants- N. Texas District #1- (December 2018-Present)

 

Fellowship Council

       Member, Diversity, Equity and Inclusion Task Force – (2020 – Present)

       Member, Nominating Committee, Fellowship Council – (2020 – 2023)

       Chair, Nominating Committee, Fellowship Council – (2019-2020)

       President, Executive, Board and Nominating Committee, Fellowship Council – (2018-2019)

       Chair, Membership Committee, Fellowship Council – (2017-2018)

       President Elect, Executive and Board Committee, Fellowship Council – (2017-2018)

       Vice President-Communications, Executive and Board Committee, Fellowship Council – 

       (2016-2017)

       Board Society Representative, Membership Committee, Fellowship Council – (2015-2017)

       Member, Unified Standards Task Force, Fellowship Council – (2015-2016)

       Member, Mission Statement Task Force, Fellowship Council – (2015-2016)

       Vice President, Finance Committee, Fellowship Council – (2014-2017)

       Chair, Communications Committee, Fellowship Council – (2014-2017)

       Vice President, Accreditation Committee, Fellowship Council – (2014 – 2016)

       Vice President, Executive and Board Committee, Fellowship Council – (2014-2016)

       Accreditation Chair, Executive and Board Committee, Fellowship Council – (2012-2014)

       Member, Research Committee, Fellowship Council – (2011-2013)

       Member, Nominating Committee, Fellowship Council – (2011-2018)

       Accreditation Co-Chair, Executive Committee, Fellowship Council – (2010-2012)

       AHPBA Representative, Board Committee, Fellowship Council – (2010-2016)

       Member of the Membership Committee, Fellowship Council – (2009-2015)

      Site reviewer, Fellowship Council- (2008-2020)

      AHPBA Representative, Accreditation Committee, Fellowship Council – (2008-2014)

 

Society of Surgical Oncology

       Disparities Committee, Society of Surgical Oncology (2009-2012)

       CME committee, Society of Surgical Oncology (2011-2013)

       Training Committee, Society of Surgical Oncology – (2013-2015)

       Program chair: An Update in HPB Surgery for the Community Surgeon SSO (March 2011)

       Member, Training Committee, SSO- (2013- 2016)

       Chair, Consensus work group ASTS/SSO Fellowship Training group- (2017-present)

 

Society for Surgery of Alimentary Tract

      Chair, Education and Training Committee, SSAT – (2023 – present)

      Vice Chair, Giving Back Committee, SSAT – (2015-2018)

      Diversity and Inclusion Task Force, SSAT – (2013-2023)

      Co-chair, Task Force 2 SSAT – (2020-present)

      Chair, Giving Back Committee, SSAT - (2018-2019)

      Member, SSAT Advanced GI Fellowship Oversight Task Force (2021 – current)

 

American Hepato-Pancreatico-Biliary Association     

      Secretary, AHPBA – (2023 – present)

      Chair, HPB Program Directors Committee AHPBA- (2009 – 2015)

      Co-Chair Education and Training Committee, AHPBA (2010-2013)

      Education Committee, AHPBA – (August 2007- 2019)

      Member, Ultrasound Subcommittee, AHPBA – (October 2017- present)

      Member, Education and Training Committee – IHPBA – (2016 – 2021)

      Chair, Consensus work group AHPBA Fellowship Training group- (2017-present)

      Member at Large, AHPBA Council – (October 2017- 2019)

      Publications Committee, AHPBA (Aug 2004-2007)

      AHPBA, Representative to the American Board of Surgery – (2020-present)

 

American Board of Surgery

      Member, EPA Scope Council, ABS – (2021-present)

      Examination Consultant, Surgery In Training Examination, ABS - (2018-present)

      Director, American Board of General Surgery (2020-present)

      Member, Diversity Equity and Inclusion Ad Hoc Committee (2021-Present)

 

Surgical Infection Society

      Education and Fellowship Committee – Surgical Infection Society (Aug 2004-2007)

      Research Committee, Surgical Infection Society (2004-2006)

 

American Surgical Association

            Fellow (2022-present)

Committees:

Communication Pillar Lead, Member Executive Committee, Board of Governors- (2019 -2020)

Co-Chair, HPB/Solid Organ Pathway Task Force, SAGES – (2017 – present)

Abstract Review Committee for 2005 Congress – Biliary Area (2005)

Moderator: Free Papers Pancreas/Biliary – 2005 Congress – (April 2005)

Reviewer Alimentary Pharmacology and Therapeutics

Reviewer Surgery

Reviewer J Surg Onc

Reviewer World Journal of Surgery

Reviewer Pancreas

Reviewer Archives of Surgery

Reviewer HPB

Reviewer Surgery

Reviewer JOGS

Member of the research advisory council, Methodist Research Institute – (2013-current)

Expert Panelist for Texas State Board of Medical Examiners – (2013-current)

Relevant Publications

Journals      

  1. Falcone PA, Barrall DT, Jeyarajah DR, Grossman JA. “Nonoperative management of full-thickness intravenous extravasation injuries in premature neonates using enzymatic debridement.” Ann Plast Surg. 1989 Feb;22(2):146-9.
  2. Jeyarajah DR, Thistlethwaite JR Jr. “General aspects of cytokine-release syndrome: timing and incidence of symptoms.” Transplant Proc. 1993 Apr;25(2 Suppl 1):16-20.
  3. Jeyarajah DR, Schmeisser FS, Josephson MA, Sohn DG, Thistlethwaite JR Jr. “Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.” Transplant Proc. 1994 Apr;26(2):771-3.
  4. Jeyarajah DR, Schmeisser FS, Kadakia RA, Thistlethwaite JR Jr. “Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation.” Transplant Proc. 1994 Jun;26(3):1201-2.
  5. Alegre ML, Peterson LJ, Xu D, Sattar HA, Jeyarajah DR, Kowalkowski K, Thistlethwaite JR, Zivin RA, Jolliffe L, Bluestone JA. “A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation.” 1994 Jun 15;57(11):1537-43.
  6. Smith DM, Bluestone JA, Jeyarajah DR, Newberg MH, Engelhard VH, Thistlethwaite JR Jr, Woodle ES. “Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.” J Immunol. 1994 Aug 1;153(3):1054-67.
  7. Alegre ML, Peterson LJ, Jeyarajah DR, Weiser M, Bluestone JA, Thistlethwaite JR. “Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.” J Immunol. 1994 Sep 15;153(6):2738-49.
  8. Jeyarajah DR, Kadakia RA, O'Toole K, Newell KA, Josephson MA, Spargo BH, Woodle ES, Thistlethwaite JR Jr. “Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection.” Transplant Proc. 1995 Feb;27(1):887-9.
  9. Abbasoglu O, Levy MF, Brkic BB, Testa G, Jeyarajah DR, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. “Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation.” 1997 Dec 27;64(12):1801-7.
  10. Jeyarajah DR, McBride M, Klintmalm GB, Gonwa TA. “Combined liver-kidney transplantation: what are the indications?” Transplantation. 1997 Oct 27;64(8):1091-6.
  11. Jeyarajah DR, Gonwa TA, McBride M, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Klintmalm GB. “Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant.” Transplantation. 1997 Dec 27;64(12):1760-5.
  12. Jeyarajah DR, Gonwa TA, Testa G, Abbasoglu O, Goldstein R, Husberg BS, Levy MF, Klintmalm GB. “Liver and kidney transplantation for polycystic disease.” Transplantation. 1998 Aug 27;66(4):529-32.
  13. Prabhakar G, Testa G, Abbasoglu O, Jeyarajah DR, Goldstein RM, Levy MF, Husberg BS, Gonwa TA, Klintmalm GB. “The safety of cardiac operations in the liver transplant recipient.” Ann Thorac Surg. 1998 Apr;65(4):1060-4.
  14. Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, Levy MF, Goldstein RM, Gonwa TA, Tillery GW, Crippin JS, Klintmalm GB. “Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?” Transplantation. 1998 Nov 27;66(10):1300-6.
  15. Testa G, Goldstein RM, Toughanipour A, Abbasoglu O, Jeyarajah R, Levy MF, Husberg BS, Gonwa TA, Klintmalm GB. “Guidelines for surgical procedures after liver transplantation.” Annals of surgery. 1998 Apr;227(4):590.
  16. Jeyarajah DR, Klintmalm GB. “Is liver transplantation indicated for cholangiocarcinoma?” J Hepatobiliary Pancreat Surg. 1998;5(1):48-51.
  17. Jeyarajah DR, Kielar M, Penfield J, Lu CY. “Docosahexaenoic acid, a component of fish oil, inhibits nitric oxide production in vitro.” J Surg Res. 1999 May 15;83(2):147-50.
  18. Lu CY, Penfield JG, Kielar ML, Vazquez MA, Jeyarajah DR. “Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process?” Kidney Int. 1999 Jun;55(6):2157-68.
  19. Penfield JG, Dawidson IA, Ar'Rajab A, Kielar MA, Jeyarajah DR, Lu CY. “Syngeneic renal transplantation increases the number of renal dendritic cells in the rat.” Transpl Immunol. 1999 Dec;7(4):197-200.
  20. Penfield JG, Wang Y, Li S, Kielar MA, Sicher SC, Jeyarajah DR, Lu CY. “Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney.” Kidney Int. 1999 Nov;56(5):1759-69.
  21. Scott DJ, Bergen PC, Euhus DM, Guo W, Jeyarajah DR, Laycock R, Rege RV, Tesfay ST, Thompson WM, Valentine RJ, Jones DB. “Intense laparoscopic skills training improves operative performance of surgery residents.” Am College of Surgeons, Surgical Forum. 670-671, 1999.
  22. Kielar ML, Jeyarajah DR, Penfield JG, Lu CY. “Docosahexaenoic acid decreases IRF-1 mRNA and thus inhibits activation of both the IRF-E and NFkappa d response elements of the iNOS promoter.” Transplantation. 2000 May 27;69(10):2131-7.
  23. Meyer P, Nwariaku O, McClelland RN, Gibbons D, Leach F, Sagalowsky AI, Simmang C, Jeyarajah DR. “Rare presentation of actinomycosis as an abdominal mass: report of a case.” Dis Colon Rectum. 2000 Jun;43(6):872-5.
  24. Scott DJ, Bergen PC, Rege RV, Laycock R, Tesfay ST, Valentine RJ, Euhus DM, Jeyarajah DR, Thompson WM, Jones DB. “Laparoscopic training on bench models: better and more cost effective than operating room experience?” J Am Coll Surg. 2000 Sep;191(3):272-83. 
  25. Kielar ML, Sicher SC, Penfield JG, Jeyarajah DR, Lu CY. “Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator.” Inflammation. 2000 Oct;24(5):431-45.
  26. Vazquez MA, Jeyarajah DR, Kielar ML, Lu CY. “Long-term outcomes of renal transplantation: a result of the original endowment of the donor kidney and the inflammatory response to both alloantigens and injury.” Curr Opin Nephrol Hypertens. 2000 Nov;9(6):643-8.
  27. Jeyarajah DR. “Localized Hepatocellular Carcinoma.” Curr Treat Options Gastroenterol. 2000 Dec;3(6):463-472.
  28. Scott DJ, Young WN, Watumull LM, Lindberg G, Fleming JB, Huth JF, Rege RV, Jeyarajah DR, Jones DB. “Accuracy and effectiveness of laparoscopic vs open hepatic radiofrequency ablation.” Surg Endosc. 2001 Feb;15(2):135-40.
  29. Burdick JS, Garza AA, Magee DJ, Dykes C, Jeyarajah R. “Endoscopic management of afferent loop syndrome of malignant etiology.” Gastrointest Endosc. 2002 Apr;55(4):602-5.
  30. Kielar ML, Rohan Jeyarajah D, Lu CY. “The regulation of ischemic acute renal failure by extrarenal organs.” Curr Opin Nephrol Hypertens. 2002;11(4):451‐457.
  31. Kielar ML, Jeyarajah DR, Zhou XJ, Lu CY. “Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase.” J Am Soc Nephrol. 2003 Feb;14(2):389-96.
  32. Jeyarajah DR, Kielar ML, Zhou XJ, Zhang Y, Lu CY. “Acute bile duct ligation ameliorates ischemic renal failure.” Nephron Physiol. 2003;95(2):p28-35.
  33. Jeyarajah DR, Kielar ML, Frantz N, Lindberg G, Lu CY. “Infection by gram-negative organisms via the biliary route results in greater mortality than portal venous infection.” Clin Diagn Lab Immunol. 2003 Jul;10(4):664-9.
  34. Jeyarajah DR, Kielar M, Gokaslan ST, Lindberg G, Lu CY. “Fas deficiency exacerbates cerulein-induced pancreatitis.” J Invest Surg. 2003 Nov- Dec;16(6):325-33.
  35. Jeyarajah DR. “Recurrent Pyogenic Cholangitis.” Curr Treat Options Gastroenterol. 2004 Apr;7(2):91-98.
  36. Zhang Y, Woodward VK, Shelton JM, Richardson JA, Zhou XJ, Link D, Kielar ML, Jeyarajah DR, Lu CY. “Ischemia-reperfusion induces G-CSF gene expression by renal medullary thick ascending limb cells in vivo and in vitro.” Am J Physiol Renal Physiol. 2004 Jun;286(6):F1193-201.
  37. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, Jeyarajah DR, Zhou XJ, Zhou H, Chiquett B, Nagami GT, Lu CY. “Maladaptive role of IL-6 in ischemic acute renal failure.” J Am Soc Nephrol. 2005 Nov;16(11):3315-25.
  38. Bell CL, Jeyarajah DR. “Management of the cirrhotic patient that needs surgery.” Curr Treat Options Gastroenterol. 2005 Dec;8(6):473-80.
  39. Mayo MJ, Mosby JM, Jeyarajah R, Combes B, Khilnani S, Al-halimi M, Handem I, Grammer AC, Lipsky PE. “The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases.” Liver Int. 2006 Mar;26(2):187-96.
  40. Bell C, Yorgason J, Jessen ME, Josephs S, Jain T, Jeyarajah DR. “Management of hepatic and intracardiac echinococcal cysts: case report and review of the literature.” Surg Infect (Larchmt). 2006 Jun;7(3):309-13.
  41. Jeyarajah DR, Kielar ML, Saboorian H, Karimi P, Frantz N, Lu CY. “Impact of bile duct obstruction on hepatic E. coli infection: role of IL-10.” Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G91-4.
  42. Hamilton L, Jeyarajah DR. “Hemoglobin A1c can be helpful in predicting progression to diabetes after Whipple procedure.” HPB (Oxford). 2007;9(1):26-8.
  43. Jeyarajah, DR. “Minimally Invasive surgeries can remove tumors of the esophagus, liver, and pancreas.” Dallas Medical Journal. 93(5), 2007 May.
  44. Rassadi R, Tarnasky PR, Linder JD, Saad AJ, Jeyarajah DR. “Nodal sampling in pancreaticoduodenectomy: does it change our management?” HPB (Oxford). 2007;9(6):461-5.
  45. Rassadi R, Jolley TM, Saad AJ, Jeyarajah DR, Tarnasky PR. “A rare form of annular pancreas: annular duct originating from the duct of Santorini.” Gastrointest Endosc. 2008 Mar;67(3):544-5.
  46. Sokolich, J, MD, Gonzalez, MV, MD, Jeyarajah, DR, MD, Rassadi, RR, MD, Dunn, E, MD. “Hepatic echinoccocal cyst presenting as anaphylactic shock.” DMJ. 94 (3), 2008 March.
  47. Rassadi R, Dickerman RM, Dunn EL, Tarnasky PR, Linder JD, Mejia A, Cheng SS, Jeyarajah DR. “Hepatopancreaticobiliary (HPB) surgery: what is the right fellowship for the right training?” J Surg Educ. 2008 May-Jun;65(3):186-90.
  48. Moldrem AW, Papaconstantinou H, Broker H, Megison S, Jeyarajah DR. “Late presentation of intestinal malrotation: an argument for elective repair.” World J Surg. 2008 Jul;32(7):1426-31.
  49. Hankins D, Chao S, Dolmatch BL, Jeyarajah RD. “Covered stents for late postoperative arterial hemorrhage after pancreaticoduodenectomy.” J Vasc Interv Radiol. 2009 Mar;20(3):407-9.
  50. Khithani AS, Curtis DE, Galanopoulos C, Jeyarajah DR. “Pancreaticoduodenectomy after a Roux-en-Y gastric bypass.” Obes Surg. 2009 Jun;19(6):802-5.
  51. Tarnasky PR, Linder JD, Mejia A, Dickerman R, Jeyarajah R, Cheng SS. “Bile duct obstruction after cholecystectomy caused by clips: undo what has been undone, then do what you normally do.” Gastrointest Endosc. 2009 Apr;69(4):e19-21.
  52. Sokolich J, Galanopoulos C, Dunn E, Linder JD, Jeyarajah DR. “Expanding the indications for laparoscopic gastric resection for gastrointestinal stromal tumors.” JSLS. 2009 Apr-Jun;13(2):165-9.
  53. Khithani A, Jay J, Galanopoulos C, Curtis D, Vo A, Jeyarajah DR. “Zero leaks with minimally invasive esophagectomy: a team-based approach.” JSLS. 2009 Oct-Dec;13(4):542-9.
  54. Khithani A, Curtis D, Dickerman R, Jeyarajah DR. “Extended drainage of the pancreatic duct after pancreaticoduodenectomy.” Arch Surg. 2009 Dec;144(12):1163-6.
  55. Jeyarajah DR, Khithani A, Curtis D, Galanopoulos CA. “The 'Whip-Stow' procedure: an innovative modification to the whipple procedure in the management of premalignant and malignant pancreatic head disease.” Am Surg. 2010 Jan;76(1):70-2.
  56. Christian DJ, Khithani A, Castro-Arreola ME, Levitan D, Jeyarajah DR. “Surgical management of gastric varices and morbid obesity: a novel approach.” Surg Obes Relat Dis. 2010 Jul-Aug;6(4):448-50.
  57. Christian DJ, Khithani A, Jeyarajah DR. “Making liver transection even safer: a novel use of microwave technology.” Am Surg. 2011 Apr;77(4):417-21.
  58. Chahal P, Saad AJ, Jeyarajah RD. “An unusual case of a coexistent serous cystadenoma and intraductal papillary mucinous neoplasm of pancreas. EUS to the rescue!” JOP. 2011 May 6;12(3):244-6.
  59. Khithani A, Christian D, Lowe K, Saad AJ, Linder JD, Tarnasky P, Jeyarajah DR. “Feasibility of pancreaticoduodenectomy in a non-university tertiary care center: what are the key elements of success?” Am Surg. 2011 May;77(5):545-51.
  60. Lowe K, Jeyarajah DR. “Integration of Surgery and Radioembolization i n Treatment of Hepatic Tumors.” J Nucl Med Radiat Ther. 2011;2:1 DOI: 10.4172/2155-9619.1000105
  61. Lowe K, Khithani A, Mejia A, Cheng S, Jeyarajah DR. “All lymph node positive patients are not equal: a new paradigm in gallbladder cancer.” Am Surg. 2012 Jan;78(1):147-8.
  62. Lowe K, Khithani A, Liu E, Winston T, Christian D, Saad J, Jeyarajah DR. “Ki-67 labeling: a more sensitive indicator of malignant phenotype than mitotic count or tumor size?” J Surg Oncol. 2012 Nov;106(6):724-7.
  63. Mattar SG, Alseidi AA, Jones DB, Jeyarajah DR, Swanstrom LL, Aye RW, Wexner SD, Martinez JM, Ross SB, Awad MM, Franklin ME, Arregui ME, Schirmer BD, Minter RM. “General surgery residency inadequately prepares trainees for fellowship: results of a survey of fellowship program directors.” Ann Surg. 2013 Sep;258(3):440-9.
  64. Rohan Jeyarajah D, Osman HG, Patel S. “Severe acute pancreatitis attacks are associated with significant morbidity and mortality.” Curr Probl Surg. 2014;51(9):370‐372.
  65. Rohan Jeyarajah D, Osman HG, Patel S. “Advances in management of pancreatic necrosis.” Curr Probl Surg. 2014;51(9):374‐408.
  66. Jeyarajah DR, Khithani A, Siripurapu V, Liu E, Thomas A, Saad AJ. “Lymph node retrieval in pancreaticoduodenectomy specimens: does educating the pathologist matter?” HPB (Oxford). 2014 Mar;16(3):263-6.
  67. Patel S, Cheek S, Osman H, Jeyarajah DR. “MRI with gadoxetate disodium for colorectal liver metastasis: is it the new "imaging modality of choice"?” J Gastrointest Surg. 2014 Dec;18(12):2130-5.
  68. Jeyarajah DR, Patel S, Osman H. “The current state of hepatopancreatobiliary fellowship experience in North America.” J Surg Educ. 2015 Jan-Feb;72(1):144-7.
  69. Osman H, Parikh J, Patel S, Jeyarajah DR. “Are general surgery residents adequately prepared for hepatopancreatobiliary fellowships? A questionnaire-based study.” HPB (Oxford). 2015 Mar;17(3):265-71.
  70. Ali N, O'Rourke C, El-Hayek K, Chalikonda S, Jeyarajah DR, Walsh RM. “Estimating the need for hepato-pancreatico-biliary surgeons in the USA.” HPB (Oxford). 2015 Apr;17(4):352-6.
  71. Bankhead-Kendall B, Patel S, Saad J, Jeyarajah DR. “Elevated fluid CEA levels in a pancreatic lymphoepithelial cyst.” Am Surg. 2015 May;81(5):E228-9.
  72. Seshadri RM, Ali N, Warner S, Cochran A, Vrochides D, Iannitti D, Jeyarajah DR. “Training and practice of the next generation HPB surgeon: analysis of the 2014 AHPBA residents' and fellows' symposium survey.” HPB (Oxford). 2015 Dec;17(12):1096-104.
  73. Minter RM, Alseidi A, Hong JC, Jeyarajah DR, Greig PD, Dixon E, Thumma JR, Pawlik TM. “Training in Hepatopancreatobiliary Surgery: Assessment of the Hepatopancreatobiliary Surgery Workforce in North America.” Ann Surg. 2015 Dec;262(6):1065-70.
  74. Bressan AK, Edwards JP, Grondin SC, Dixon E, Minter RM, Jeyarajah DR, Ball CG. “The adequacy of Hepato-Pancreato-Biliary training: how closely do perceptions of fellows and programme directors align?” HPB (Oxford). 2015 Sep;17(9):791-5.
  75. Jeyarajah DR, Berman RS, Doyle MB, Geevarghese SK, Posner MC, Farmer D, Minter RM. “Consensus Conference on North American Training in Hepatopancreaticobiliary Surgery: A Review of the Conference and Presentation of Consensus Statements.” Am J Transplant. 2016 Apr;16(4):1086-93.
  76. Sheikh MR, Osman H, Cheek S, Hunter S, Jeyarajah DR. “Duodenal Neuroendocrine Tumors: Location Matters!” Am Surg. 2016 May;82(5):386-9.
  77. Baker EH, Dowden JE, Cochran AR, Iannitti DA, Kimchi ET, Staveley-O'Carroll KF, Jeyarajah DR. “Qualities and characteristics of successfully matched North American HPB surgery fellowship candidates.” HPB (Oxford). 2016 May;18(5):479-84.
  78. Butt MU, Sheikh MR, Osman H, Jeyarajah DR. “Change in Perception of training in Hepato-pancreato-biliary Surgery among Senior General Surgery Residents: AHPBA Fellowships on the rise!” HPB. 2016 April. 18(12): 1039–1045.
  79. Walsh RM, Jeyarajah DR, Matthews JB, Telem D, Hawn MT, Michelassi F, Reid-Lomardo KM. “White Paper: SSAT Commitment to Workforce Diversity and Healthcare Disparities.” J Gastrointest Surg. 2016 May;20(5):879-84.
  80. Sheikh MR, Osman H, Cheek S, Hunter S, Jeyarajah DR. “T2 Gallbladder Cancer-Aggressive Therapy Is Warranted.” Am Surg. 2016 Jun;82(6):518-21. 
  81. Jeyarajah DR, Berman RS, Doyle M, Geevarghese SK, Posner MC, Farmer D, Minter RM. “Consensus Conference on North American Training in Hepatopancreaticobiliary Surgery: A Review of the Conference and Presentation of Consensus Statements.” Ann Surg Oncol. 2016 Jul;23(7):2153-60.
  82. Baker EH, Siddiqui I, Vrochides D, Iannitti DA, Martinie JB, Rorabaugh L, Jeyarajah DR, Swan RZ. “Building the Nonuniversity, Tertiary Care Center Hepatobiliary and Pancreatic Surgery Practice: Structural and Financial Considerations.” Am Surg. 2016 Dec 1;82(12):1196-1202.
  83. Sheikh MR, Osman H, Butt MU, Jeyarajah DR. “Perception of training in hepatopancreatobiliary surgery among general surgery residents in the Americas.” HPB (Oxford). 2016 Dec;18(12):1039-1045.
  84. Kennedy GT, McMillan MT, Sprys MH, Bassi C, Greig PD, Hansen PD, Jeyarajah DR, Kent TS, Malleo G, Marchegiani G, Minter RM, Vollmer CM Jr. “The influence of fellowship training on the practice of pancreatoduodenectomy.” HPB (Oxford). 2016 Dec;18(12):965-978.
  85. Hogg ME, Besselink MG, Clavien PA, Fingerhut A, Jeyarajah DR, Kooby DA, Moser AJ, Pitt HA, Varban OA, Vollmer CM, Zeh HJ 3rd, Hansen P; “Training in Minimally Invasive Pancreatic Resections: a paradigm shift away from "See one, Do one, Teach one".” HPB (Oxford). 2017 Mar;19(3):234-245.
  86. Aubin JM, Bressan AK, Edwards JP, Grondin SC, Dixon E, Minter RM, Jeyarajah DR, Hansen P, Cooper AB, Ball CG. “The adequacy of hepatopancreatobiliary training: How does operative exposure and perceived readiness in fellowship translate into subsequent practice?” Can J Surg. 2017 Apr;60(2):140-143.
  87. Pardo F, Sangro B, Lee RC, Manas D, Jeyarajah R, Donckier V, Maleux G, Pinna AD, Bester L, Morris DL, Iannitti D, Chow PK, Stubbs R, Gow PJ, Masi G, Fisher KT, Lau WY, Kouladouros K, Katsanos G, Ercolani G, Rotellar F, Bilbao JI, Schoen M. “The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.” Ann Surg Oncol. 2017 Sep;24(9):2465-2473.
  88. Gdowski A, Osman H, Butt U, Foster S, Jeyarajah DR. “Undiagnosed Liver Fibrosis in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.” World J Surg. 2017 Nov;41(11):2854-2857.
  89. Watkins JR, Truitt MS, Osman H, Jeyarajah RD. “Biologic Keyhole Mesh in Hiatal Hernia Repair.” JSLS. 2018 Jan-Mar;22(1):e2017.00086.
  90. Watkins JR, Pryor AD, Truitt MS, Jeyarajah DR. “Perception versus reality: elucidating motivation and expectations of current fellowship council minimally invasive surgery fellows.” Surg Endosc. 2018 Nov;32(11):4422-4427.
  91. Cho EE, Osman H, Dietemann D, Jeyarajah DR. “The importance of assessing the SMA margin in patients undergoing pancreaticoduodenectomy.” Int J Hepatobiliary Pancreat Dis. 2019 Jan 21;9:100082Z04EC2019.
  92. Jackson T, Cho EE, Osman HG, Jeyarajah DR. “Trainee and teacher learning together: dual console and the three arms.” HPB. 2019 Mar 1;21:S163.
  93. Washington K, Watkins JR, Jay J, Jeyarajah DR. “Oncologic Resection in Laparoscopic Versus Robotic Transhiatal Esophagectomy.” JSLS. 2019 Apr- Jun;23(2):e2019.00017.
  94. Weis JJ, Alseidi AA, Jeyarajah DR, Schweitzer MA, Hori Y, Cheung V, Scott DJ. “Providing complex GI surgical care with minimally invasive approaches: a survey of the practice patterns of Fellowship Council alumni.” Surgical endoscopy. 2020 Apr 34(4):1776-1784.
  95. Kurtz J, Lim J, Borscheid R, Cho E, Osman H, Jeyarajah DR. “Learning curve from laparoscopic to robotic Heller myotomy. A myth?” GME Research Journal, Methodist Health System. Spring Issue. June 2019.
  96. Pagkratis S, Cho EE, Lewis F, Miller K, Osman H, Doyle MBM, Jeyarajah DR. “Expectations of Hepato-Pancreato-Biliary Fellows; Do We Meet Them?” J Surg Educ. 2019 Nov-Dec;76(6):1546-1555.
  97. Kennedy GD, Lidor A, Jeyarajah DR, Walsh M, Hassan I, Soper N, Callery M, Ashley SW, Stain SC; Board of Directors of the Society for Surgery of the Alimentary Tract. “Looking Ahead: the SSAT Strategic Plan Version 2.0 for the Next Decade.” J Gastrointest Surg. 2019 Nov 25.
  98. Moekotte AL, Rawashdeh A, Asbun HJ, Coimbra FJ, Edil BH, Jarufe N, Jeyarajah DR, Kendrick ML, Pessaux P, Zeh HJ, Besselink MG, Abu Hilal M, Hogg ME; “Safe implementation of minimally invasive pancreas resection: a systematic review.” HPB (Oxford). 2020 Jan 271(1):1-14.
  99. Garlipp B, Gibbs P, Van Hazel GA, Jeyarajah R, Martin RC, Bruns CJ, Lang H, Manas DM, Ettorre GM, Pardo F, Donckier V. “Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.” British journal of surgery. 2019 Dec 1.
  100. Passeri M, Picken R, Martinie J, Vrochides D, Baker E, Jeyarajah DR, Hagopian EJ, Vollmer CM Jr, Iannitti D. “The annual AHPBA HPB fellows' course: an analysis of impact and feedback.” HPB (Oxford). 2020 Jan 30:S1365-182X(19)33188-0.
  101. Asbun HJ, Moekotte AL, Vissers FL, et al. International Study Group on Minimally Invasive Pancreas Surgery (I-MIPS). “The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection.” Ann Surg. 2020 Jan;271(1):1-14.
  102. Lim JS, Kurtz J, Borscheid R, Cho E, Osman H, Jeyarajah DR. “Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs) of the Esophagus.” Am Surg. 2020 Feb 1;86(2):e101-e103.
  103. Washington K, Watkins JR, Jeyarajah DR. “The first year is the hardest: a comparison of early versus late experience after the introduction of robotic hiatal hernia repair.” J Robot Surg. 2020 Feb;14(1):205-210.
  104. Cho EE, Maruyama K, Hutter M, Osman H, Jeyarajah DR. “Advanced Gastrointestinal Surgery Fellowship Graduates Are Desirable to Current US General Surgery Practices: Results of a SSAT Sponsored Survey.” J Gastrointest Surg. 2020 Mar;24(3):695-700.
  105. Jackson T, Cho EE, Nagatomo K, Osman HG, Jeyarajah DR. “Teacher and Trainee Learning Together-Dual Console and the 3 Arms.” J Surg Educ. 2020 Mar 4:S1931-7204(20)30013-1.
  106. Jeyarajah DR, Doyle MBM, Espat NJ, Hansen PD, Iannitti DA, Kim J, Thambi-Pillai T, Visser BC. “Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm.” J Gastrointest Oncol. 2020 Apr;11(2):443-460.
  107. Weis JJ, Alseidi AA, Jeyarajah DR, Schweitzer MA, Hori Y, Cheung V, Scott DJ. “Providing complex GI surgical care with minimally invasive approaches: a survey of the practice patterns of Fellowship Council alumni.” Surg Endosc. 2020 Apr;34(4):1776-1784.
  108. Osman H, Jeyarajah DR. “Pancreas Cystic Lesions.” Surg Clin North Am. 2020 Jun;100(3):581-588.
  109. Siriwardhane M, Bhandari RS, Dissanayake B, Galketiya K, Lakhey PJ, Mar TT, Pathirana A, Siriwardena AK, Rohan Jeyarajah D. “An International Group of Hepatopancreaticobiliary Surgeons Respond to the COVID-19 Pandemic.” The American Surgeon. 2020 Jun;86(6):591-5.
  110. Michael Brunt L, Deziel DJ, Telem DA, Strasberg SM, Aggarwal R, Asbun H, Bonjer J, McDonald M, Alseidi A, Ujiki M, Riall TS, Hammill C, Moulton CA, Pucher PH, Parks RW, Ansari MT, Connor S, Dirks RC, Anderson B, Altieri MS, Tsamalaidze L, Stefanidis D; Prevention of Bile Duct Injury Consensus Work Group. Safe cholecystectomy multi-society practice guideline and state-of-the-art consensus conference on prevention of bile duct injury during cholecystectomy. Surg Endosc. 2020 Jul;34(7):2827-2855.
  111. Dunn A, Walsh M, Lipman J, French J, Jeyarajah DR, Schneider E, Delaney C, Augustin T. “Can an Academic RVU Model Balance the Clinical and Research Challenges in Surgery?” J Surg Educ. 2020 Aug 5:S1931-7204(20)30164-1.
  112. Rashidian N, Willaert W, Van Herzeele I, Morise Z, Alseidi A, Troisi RI, FULCRUM Research Group. “Key components of a hepatobiliary surgery curriculum for general surgery residents: results of the FULCRUM International Delphi consensus.” HPB. 2020 Oct;22(10):1429-1441.
  113. Darwish MB, Nagatomo K, Jackson T, Cho E, Osman H, Jeyarajah DR. “Minimally Invasive Esophagectomy for Achieving R0.” JSLS. 2020 Oct;24(4).
  114. Jackson, T., Marks, J., Cho, E., Jeyarajah, DR. “Unbundling Surgery: Have we taken specialization too far?” Am Surg. 2020 Oct 29;3134820940626.
  115. Jackson T, Vedantam S, Bradshaw R, Cho E, Lim J, Nagatomo K, Osman H, Jeyarajah DR. “Unrecognized Anemia After Whipple–Should We Learn from Gastric Bypass?.” Expert Review of Gastroenterology & Hepatology. 2020 Nov 1; 14(11):1119-23. 1-5.doi:10.1080/17474124.2020.1808459
  116. Lim JS, Jackson T, Kurtz J, Cho EE, Vedantam S, Nagatomo K, Osman H, Jeyarajah DR. “Overcoming the Arduous Transition for Robotic Hepatopancreatobiliary Cases: A Multi-Procedure Learning Curve Study Utilizing CUSUM Analysis.” World Journal of Surgery. 2020 Nov 27:1-8.
  117. Nagatomo K, Darwish M, Cho E, Jackson T, Osman H, Jeyarajah DR. “SSAT-sponsored Advanced GI (AGI) fellowship Programs: filling a space in surgical training?” Journal of Surgical Education. 2021 Jan 28.
  118. Jackson T, Lim J, Cho E, Osman H, Nagatomo K, Jeyarajah DR. “Hepatopancreatobiliary Fellowship Graduates: Where do They Stand today?” The American Surgeon. 2021 Feb 10; 0(0) 1-6.
  119. Ojha S, Darwish M, McLaren P, Benzie A, Cho E, Osman H, Jeyarajah DR. “Pancreatic Cystic Lymphangioma: Case Report and Literature Review”. Journal of Current Surgery. 2021 Feb 26; 11(1), 24-27.
  120. Jackson T, Darwish M, Cho E, Nagatomo K, Osman H, Jeyarajah DR. “68Ga-DOTATATE PET/CT Compared to Standard Imaging in Metastatic Neuroendocrine Tumors: A More Sensitive Test to Detect Liver Metastasis?” Abdominal Radiology. 2021 Mar 4.
  121. Rivera K, Jeyarajah DR, Washington K. “Hepatectomy, RFA, and Other Liver Directed Therapies for Treatment of Breast Cancer Liver Metastasis: A Systematic Review”. Frontiers in Oncology. 2021 Mar 26; 11:312
  122. Jackson T, Lim JS, Nagatomo K, Darwish M, Cho E, Osman H, Jeyarajah DR. "Investigating Factors at Play in Hepatopancreatobiliary Fellowship Selection: Beliefs versus Reality". World Journal of Surgery. 2021 Apr 19: 1-1.
  123. Jeyarajah DR, Abouljoud M, Alseidi A, Berman R, D’Angelica M, Hagopian E, Pawlik TM. “Training Paradigms in Hepato-Pancreatico-Biliary Surgery: an Overview of the Different Fellowship Pathways.” Journal of Gastrointestinal Surgery. 2021 May 4:1-0.
  124. Darwish M, Osman H, Cho E, Kabbani W, Jackson T, Nagatomo K, Jeyarajah DR. “Case Report: A Case of Intracholecystic Papillary-Tubular Neoplasm.” Journal of Current Surgery. 2021 June; 11(2):35-38
  125. Machado NN, Jackson T, Arumugham A, Jeyarajah DR. “Intra-Arterial Vasopressin in Post-Pancreatectomy Hemorrhage: Re-familiarizing Current Surgical Trainees with a Once Novel Technique.” Journal of Current Surgery. 2021 June; 11(2):39-41.
  126. Nagatomo K, Cho E, Darwish M, Jackson T, Osman H, Stain SC, Jeyarajah DR. “Advanced Gastrointestinal Surgery Fellowship Programs: Filling a Gap in Surgical Training?” Journal of Surgical Education. 2021 September; 78(5):1593-1598
  127. Brant N, Darwish M, Osman H, Cho E, McLaren P, Benzie A, Kabbani W, Jeyarajah DR. “An unusual case of biliary cystadenoma: a case report and review of the literature”. Journal of Current Surgery. 2023 January. Available online.
  128. Chung C, Darwish M, McLaren P, Benzie A, Kabbani W, Cho E, Osman H, Jeyarajah DR. “An Adenoneuroendocrine Collision Tumor of the Pancreas: A Case Report” Journal of Current Surgery. 2021; 11(4):87-96
  129. Darwish M, Logarajah S, McLaren P, Benzie A, Schmidt J, Saad AJ, Salicru M, Jackson T, Vedantam S, Carenza J, Sanders C, Nagatomo K, Cho E, Osman H, Jeyarajah DR. Journal of Pancreatic Cancer. 2022;8(1):9-14
  130. Darwish M, Logarajah S, Nagatomo K, Jackson T, Benzie AL, McLaren PJ, Cho E,  Osman H, Jeyarajah DR. “To Wrap or Not to Wrap after Robotic Heller's Myotomy?”. JSLS Oct-Dec 2021;25(4):e2021.00054.
  131. Benzie A, Darwish M, Basta A, McLaren PJ, Cho E, Osman H, Jay J, Jeyarajah DR. “Hiatal Hernia after esophagectomy: A single center retrospective analysis of a rare post-operative phenomenon”. Am Surg. 2023;89(6):2820-2823.
  132. Darwish M, Logarajah S McLaren P, Campilan B, Benzie A, Osman, Cho E, Jeyarajah DR. “Pancreatic Cystogastrostomy: Definitive or Temporizing Procedure?”. Surg Laparosc Endosc Percutan Tech. 2023;33(1):18-21.
  133. Hagopian EJ, Zyromski NJ, Jeyarajah DR, Berber E, Park YS, Park, C, Yudkowski R. “Mastery Skill Assessment in Hepato-Pancreato-Biliary Surgical Ultrasound: It’s a Matter of Entrustment”. The American Surgeon. 2022 May, 223(5):905-911
  134. Benzie AL, Subramaniam S, Kabbani W, Lartchenko S, Jeyarajah DR. “A Mimic of Malignancy: Gastric Mucormycosis related to use of a supplement” Surgical Infections. 2022 Mar;23(2):203-204.
  135. Pryor AD, Wolbrom DH, Lidor A, Jeyarajah DR, Mattar S, Brunt M. “Gender Disparities in Gastrointestinal Surgery Fellowship Programs”. Surgical Endoscopy. 2022 Jun;26(6):3805-3810.
  136. Logarajah SI, Moslim MA, Jeyarajah DR. “The Windsock sign: a pathognomonic sign of internal duodenal diverticulum”. Journal of Gastrointestinal Surgery. 2022 Mar;26(3):710-712.
  137. Logarajah SI, Jackson T, Darwish MB, Nagomoto K, Cho EE, Osman H, Jeyarajah DR. “Whipple Pancreaticoduodenectomy: A Technical Illustration”. Surgery Open Science. 2021 Dec 8;7:62-67
  138. Gdowski A, Hayatshahi H, Fudala R, Joshi R, Liu J, Vishwanatha J, Jeyarajah DR, Guzik P, Ranjan A. “Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer”. Pharmaceutics. 2022 Jan 5;14(1):128.
  139. Logarajah SI, Darwish M, Jeyarajah DR. “Pelvic Chordoma: A Multidisciplinary Surgical Effort.” Journal of Gastrointestinal Surgery. 2022 Apr;26(4):987-988
  140. Collings AT, Jeyarajah DR, Hanna NM , Dort J, Tsuda S, Nepal P, Lim R, Lin C, Hong JS, Ansari MT, Slater BJ, Pryor AD, Kohn GP. “SAGES 2022 guidelines regarding the use of laparoscope in the era of COVID-19”. Surgical Endoscopy. 2022 May;36(5):2723-2733
  141. Sharma NK, Kappadath SC, Chuong M, Folkert M, Gibbs P, Jabbour SK, Jeyarajah DR, Kennedy A, Liu D, Meyer JE, Mikell J, Patel RS, Yang G, Mourtada F. “The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors”. Brachytherapy. 2022 May 19;S1538-4721(22)00072-1
  142. Jureller M, Logarajah SI, Van Meter TA, Osman H, Jay J, Maitham M, Ralph A, Jeyarajah RD. The Novel Conduit: Challenges of Esophagectomy After Bariatric Surgery. J Gastrointest Surg. Published online August 12, 2022.
  143. Darwish, M. B., Logarajah, S., McLaren, P. J., Benzie, A. L., Schmidt, J., Saad, A. J., Salicru, M., Jackson, T., Vedantam, S., Carenza, J., Sanders, C., Nagatomo, K., Cho, E., Osman, H., Jeyarajah, D. R. (2022). “Infiltrative” Versus “Mass-Forming” Pancreatic Cancer: A New Radiological Classification System for Pancreatic Head Ductal Carcinoma and Its Pathological Correlation. Journal of Pancreatic Cancer, 8(1), 9–14.
  144. Hanson MN, Pryor AD, Jeyarajah DR, et al. Implementation of entrustable professional activities into fellowship council accredited programs: a pilot project. Surg Endosc. Published online August 16, 2022.
  145. Logarajah SI, Karumuri J, Ahle D, Jeyarajah DR. Roux-en-Y Gastrojejunostomy: is it an effective treatment for complex hiatal hernias in the morbidly obese? Surg Endosc. Published online August 19, 2022.
  146. Ozair A, Collings A, Adams AM, et al. Minimally invasive versus open hepatectomy for the resection of colorectal liver metastases: a systematic review and meta-analysis. Surg Endosc. Published online September 22, 2022.
  147. Brant N, Apple D, Downs M, Stadler R, Rohan Jeyarajah D. Adenoma Detection Rate on Colonoscopy: an Argument for Focused Screening? J Gastrointest Surg. 2022;26(9):1954-1956.
  148. Logarajah S, Jeyarajah P, Darwish M, Moslim M, Jureller M, Osman H, Jeyarajah DR (2022) Does chemotherapy regimen matter in the neoadjuvant treatment of esophageal cancer? Journal of Gastrointestinal Oncology 13.
  149. Brant N, Lim J, Apple D, Stadler R, Downs M, Jeyarajah R. Minimally Invasive Lower Anterior Resections - Better Than Open But Not All The Same. Am Surg. 2022 Dec 5:31348221117038.
  150. Benzie AL, Logarajah S, Darwish M, Nagamoto K, Cho EE,  Riall TS, Jeyarajah DR. “A Self-Selecting Prophecy: Prevalence of Burnout in Surgical Fellows.” Surg Endosc. 2023;37(6):4926-4933. doi:10.1007/s00464-022-09634-8
  151. Logarajah SI, Cudworth S, Doty M, Darwish M, Jay J, Osman H, Jeyarajah DR. “Factors Associated With Anastomotic Leak After Transhiatal Esophagectomy, A Single Institution Analysis”. J Gastrointest Surg. 2023;27(2):398-401. doi:10.1007/s11605-022-05470-2
  152. Logarajah SI, Doty M, Moslim M, Rahman Z, Basta A, Osman H, Jeyarajah DR. “Location an signet cell features in locally advanced gastric cancer: does it matter?” J Gastrointest Surg. 2023;27(4):701-704. doi:10.1007/s11605-022-05506-7
  153. Ojha S, Logarajah S, Darwish M, Benzie A, McLaren P, Osman H, Cho E, Jay J, Jeyarajah DR. “Esophagectomy in octogenarians: Is it at a cost?” Heliyon. 2022 Nov 28;8(12):e11945.
  154. Logarajah SI, Karumuri J, Ahle D, Darwish M, Jureller M, Osman H, Jeyarajah DR. “Obesity is correlated to prior paraesophageal repair failure: experience from a non-university tertiary care center.” J Gastrointest Surg. 2023;27(4):786-789. doi:10.1007/s11605-022-05505-8
  155. Mitchell W, Roser T, Heard J, Logarajah S, Ok J, Jay J, Osman H, Jeyarajah DR. Regional Anesthetic Use in Trans-Hiatal Esophagectomy. Are They Worth Consideration? A Case Series. Local Reg Anesth. 2023;16:99-111
  156. Roser T, Mitchell W, Heard J, Ok J, Jay J, Osman H, Jeyarajah RD. Immediate Extubation Post Esophagectomy Possible: What are the Risk Factors for Failure? Accepted at Local and Regional Anesthesia. 2023
  157. Jeyarajah DR et al. SAGES/AHPBA Guidelines for the Use of Minimally Invasive Surgery for the Surgical Treatment of Colorectal Liver Metastases (CRLM). Surg Endosc. 2023 Apr;37(4):2508-2516.
  158. Heard J, Darian S, Osman H, Van Meter T, Jeyarajah DR. Colorectal Liver Metastasis Survival After Yittrium-90 (Y-90) Radioembolization: a 3-Year Experience. Revisions requested by Cancer Reports 06/2023.
  159. Darwish, M. B., Logarajah, S., McLaren, P. J., Campilan, B., Benzie, A. L., Cho, E., Osman, H., Jeyarajah, DR. Is Cystogastrostomy a Definitive Operation for Pancreatitis Associated Pancreatic Fluid Collections? Surg Laparosc Endosc Percutan Tech. 2023 Feb 1;33(1):18-21.
  160. Jones AT, Brethauer SA, Dent DL, Desai D, Jeyarjah DR, et al. How Does the Sequence of the American Board of Surgery Examinations Impact Pass/Fail Outcomes? [published online ahead of print, 2023 Jul 20]. Ann Surg. 2023;10.1097/SLA.0000000000006023. doi:10.1097/SLA.0000000000006023
  161. Mitchell W, Roser T, Heard J, et al. Regional Anesthetic Use in Trans-Hiatal Esophagectomy. Are They Worth Consideration? A Case Series. Local Reg Anesth. 2023;16:99-111. Published 2023 Jul 11. doi:10.2147/LRA.S398331
  162. Heard J, Smith G, Tolman A, Osman H, Jeyarajah DR. No Drain, No Problem: Serum-Based Marker Prediction of Clinically Relevant Postoperative Pancreatic Fistula. Accepted at American Surgeon 09/2023.
  163. Cassidy D, Clanahan J, Wan F, Jeyarajah DR, et al. The Impact of Virtual Interviews on the Fellowship Council Application and Main Match Process. Accepted at Surgical Endoscopy 09/2023.
  164. Logarajah S, Karumuri J, Ahle D, Osman H, Jeyarjah DR. Fundoplication at the time of paraesophageal hernia repair may not reduce post operative reflux. Accepted at Journal of Gastrointestinal Surgery 09/2023.
  165. Logarajah S, Karumuri J, Ahle D, Osman H, Jeyarajah DR. Fundoplication at the time of paraesophageal hernia repair may not reduce postoperative reflux. J Gastrointest Surg. 2024 Jan;28(1):70-71. doi: 10.1016/j.gassur.2023.11.013. 
  166. Heard JC, Smith GH, Tolman A, Karumuri JS, Osman HG, Jeyarajah RD. No Drain, No Problem: Serum-Based Marker Prediction of Clinically Relevant Postoperative Pancreatic Fistula. Am Surg. 2024 May;90(5):1074-1081. doi: 10.1177/00031348231204917. Epub 2023 Dec 27. 
  167. Ibáñez B, Jones AT, Jeyarajah DR, Dent DL, Prendergast C, Barry CL. A Look at Demographics and Transition to Virtual Assessments: An Analysis of Bias in the American Board of Surgery General Surgery Certifying Exams. J Surg Educ. 2024 Apr;81(4):578-588. doi: 10.1016/j.jsurg.2024.01.001. 
  168. Lim JS, Dominguez A, Kidd N, et al. Incipient Intracholecystic Papillary Neoplasm of the Gallbladder Without Dysplasia. Am Surg. 2024;90(11):3131-3133. doi:10.1177/00031348241257466
  169. Lim JS, Heard J, Brant N, Malo J, Kong J, Osman H, Buell J, Jeyarajah DR. Irreversible Electroporation Margin Accentuation in Pancreaticoduodenectomy: A Propensity Score Matching Analysis. Ann Surg Oncol. 2024 Jul 30. doi: 10.1245/s10434-024-15962-x. Epub ahead of print.

Danielle Giesler MD

  • At Institution Since: 2016
  • Program Director Since : 2021
  • Board Certification: Board Certified

Society Memberships

SAGES

ACS

ASCRS

Areas of Expertise

Complex GI Surgery

Teaching Qualifications

Summary of Qualifications

Internship:

General Surgery

June 2010 – July 2011

University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, United States

Residency:

General Surgery

July 2011 – June 2015

University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, United States

Fellowship:

Colon and Rectal Surgery

July 2015 – June 2016

Texas Health Presbyterian Hospital, Dallas, TX, United States

Publications/Presentations:

Publications:

Giesler DG, Casillas MA, Douglas D, Nodit L. The Painful Diversity of Proctitis in the Modern Era. The American Surgeon. Volume 81, Number 12, December 2015, pp. e408-e409(2).

Articles:

Daley BJ, Long C, Alexander AM, Giesler DM. (2014, June 24). Snakebite. Group Publishing System. Publication Status: Published.

Poster Presentations:

Giesler DM, Casillas MA. (2014). Transanal Minimally Invasive Surgery: Challenging the Limits. Poster presented at: SAGES; Salt Lake City, UT.

Giesler DM, Casillas MA. (2013). Transanal Minimally Invasive Surgery (TAMIS): An Early Experience. Poster presented at: SAGES; Baltimore, MD.

Giesler DM, Daley BJ. (2014). Serum Albumin as a Predictor of Complications in Elective Colonic Resection. Poster presented at: ASCRS; Hollywood, FL.

Giesler DM, Sams VG, Mancini G, Mancini M. (2011). Mesh vs Fixation of Injection Ports for Laparoscopic Gastric Band Procedures: Our Institution's Experience. Poster presented at: SLS; Los Angeles, CA.

Le, H., Giesler, D., Daley, B. (2014). Serum Albumin as a Predictor of Complications in Elective Colonic Resection. Poster presented at: ACS NSQIP; New York, NY.

Oral Presentation:

Giesler DM, Daley BJ. (2014). Tracheal Stenosis Based on Surgical Technique in Patients Undergoing Tracheostomy. Oral Presentation

Presented at: SESC; Savannah, GA.

Giesler, DM. (2015). Rectal Cancer and Local Excision. Oral Presentation

Presented at: Grand Rounds; University of Tennessee, Knoxville, TN.

Awards/Accomplishments:

Scott Frame Trauma Scholarship 2011

Howard C. Filston Administrative Chief Resident 2014-2015

TopDocs 2019

Membership and Honorary/Professional Societies:

American College of Surgeons, Association of Women Surgeons, American Medical Association, Ladies Auxiliary VFW, South Eastern Surgical Congress, Society of American Gastrointestinal and Endoscopic Surgeons, American Society of Colon and Rectal Surgeons, Chi Omega Sorority, Panhellenic Alumna

Division of Time

Percentage of Time Spent in Clinical Activity: 85%
Percentage of Time Spent in Research Activity:15%

Case Load as Reported By Fellow(s)

1 Fellow(s) performed 20 cases with 20 procedures during the 2025-2026 Fellowship Year.
1 Fellow(s) performed 107 cases with 157 procedures during the 2024-2025 Fellowship Year.

List of Contributing Faculty

D. Rohan Jeyarajah MD FACS 40%
Area of Expertise
HPB and Foregut Surgery
Role in Training
Program Director
   
Houssam Osman MD 25%
Area of Expertise
HPB/ Foregut Surgery
Role in Training
HPB Primary Faculty
   
Danielle Geisler MD 15%
Area of Expertise
Colorectal surgery
Role in Training
Asst. Program Director
   
Abdul El Chafic MD 10%
Area of Expertise
Advanced Endoscopy, EUS, ERCP
Role in Training
Associate Faculty
   
Joshua Kong MD 10%
Area of Expertise
HPB
Role in Training
Faculty
   

Accreditation History

Director Program Length Start End  
D. Rohan Jeyarajah Complex Gastrointestinal Surgery/Foregut 3 2023 2026  

Please visit the link below for a virtual tour of our institution.

 

https://www.methodisthealthsystem.org/methodist-richardson-medical-center/about/virtual-tour/